XML 43 R12.htm IDEA: XBRL DOCUMENT v2.4.1.9
Fair Value of Financial Instruments
12 Months Ended
Dec. 28, 2014
Fair Value of Financial Instruments (Thousands of Dollars) [Abstract]  
Fair Value of Financial Instruments
(6) Fair Value of Financial Instruments

The Company measures certain financial instruments at fair value. The fair value hierarchy consists of three levels: Level 1 fair values are based on quoted market prices in active markets for identical assets or liabilities that the entity has the ability to access; Level 2 fair values are those based on quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities; and Level 3 fair values are based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

Accounting standards permit entities to measure many financial instruments and certain other items at fair value and establish presentation and disclosure requirements designed to facilitate comparisons between entities that choose different measurement attributes for similar assets and liabilities. The Company has elected the fair value option for certain available-for-sale investments. At March 29, 2015, March 30, 2014 and December 28, 2014, these investments totaled $23,141, $37,201 and $23,560, respectively, and are included in prepaid expenses and other current assets in the consolidated balance sheets. The Company recorded net gains and interest income of $17 and $1,177 on these investments in other income, net for the quarters ended March 29, 2015 and March 30, 2014, respectively, related to the change in fair value of such instruments.


At March 29, 2015, March 30, 2014 and December 28, 2014, the Company had the following assets and liabilities measured at fair value in its consolidated balance sheets:

    
Fair Value Measurements Using:
 
  
Fair
Value
  
Quoted
Prices in
Active
Markets
for
Identical
Assets
(Level 1)
  
Significant
Other
Observable
Inputs
(Level 2)
  
Significant
Unobservable
Inputs
(Level 3)
 
March 29, 2015
        
Assets:
        
Available-for-sale securities
 
$
27,977
   
4,836
   
17,206
   
5,935
 
Derivatives
  
130,550
   
-
   
130,550
   
-
 
Total assets
 
$
158,527
   
4,836
   
147,756
   
5,935
 
                 
Liabilities:
                
Derivatives
 
$
3,513
   
-
   
3,513
   
-
 
Option agreement
  
24,920
   
-
   
-
   
24,920
 
Total liabilities
 
$
28,433
   
-
   
3,513
   
24,920
 
                 
March 30, 2014
                
Assets:
                
Available-for-sale securities
 
$
40,984
   
3,783
   
31,538
   
5,663
 
Derivatives
  
1,311
   
-
   
1,311
   
-
 
Total assets
 
$
42,295
   
3,783
   
32,849
   
5,663
 
                 
Liabilities:
                
Derivatives
 
$
33,053
   
-
   
33,053
   
-
 
Total Liabilities
 
$
33,053
   
-
   
33,053
   
-
 
                 
                 
                 
December 28, 2014
                
Assets:
                
Available-for-sale securities
 
$
28,042
   
4,482
   
17,773
   
5,787
 
Derivatives
  
69,148
   
-
   
69,148
   
-
 
Total assets
 
$
97,190
   
4,482
   
86,921
   
5,787
 
                 
Liabilities:
                
Derivatives
 
$
2,591
   
-
   
2,591
   
-
 
Option agreement
  
25,340
   
-
   
-
   
25,340
 
Total Liabilities
 
$
27,931
   
-
   
2,591
   
25,340
 

Available-for-sale securities include equity securities of one company quoted on an active public market as well as certain investments valued at net asset values quoted on private markets that are not active. These net asset values are predominantly based on underlying investments which are traded on an active market; investments are redeemable within 45 days. At March 30, 2014, the Company also held an available-for-sale investment in Brazil similar to a repurchase agreement; this investment was valued at the principal plus any interest accrued on the instrument. Lastly, the Company holds an available-for-sale investment which invests in hedge funds and contains financial instruments that are valued using certain estimates which are considered unobservable in that they reflect the investment manager's own assumptions about the inputs that market participants would use in pricing the asset or liability. The Company believes that these estimates are the best information available for use in the fair value of this investment.

The Company's derivatives consist primarily of foreign currency forward contracts. At March 30, 2014, the Company also had forward-starting interest rate swap contracts related to the anticipated issuance of the Notes Due 2021 and 2044. The Company used current forward rates of the respective foreign currencies and U.S. treasury interest rates to measure the fair value of these contracts. The option agreement included in other liabilities at March 29, 2015 and December 28, 2014, is valued using an option pricing model based on the fair value of the related investment.  Inputs used in the option pricing model include the volatility and fair value of the underlying company which are considered unobservable inputs as they reflect the Company's own assumptions about the inputs that market participants would use in pricing the asset or liability. The Company believes that this is the best information available for use in the fair value measurement. There were no changes in these valuation techniques during the first quarter of 2015.
 
The following is a reconciliation of the beginning and ending balances of the fair value measurements of the Company's financial instruments which use significant unobservable inputs (Level 3):

  
2015
  
2014
 
Balance at beginning of year
 
$
(19,553
)
  
5,484
 
Gain from change in fair value
  
568
   
179
 
Balance at end of first quarter
 
$
(18,985
)
  
5,663